Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

You may also like


Optimising COVID-19 vaccine safety surveillance in the Netherlands

By utilising automated web reporting and a triage sorting system, the pharmacovigilance centre Lareb enabled near real-time processing of over 200 000 COVID-19 vaccine AEFI reports

Research / 27 March 2023

UMC science gets personal

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 16 March 2023

Unlocking the power of real-world data – New podcast episode

Real-world data is a rich source of evidence for pharmacovigilance, but there are challenges yet to be faced before unlocking its true potential as a resource.

Research / 31 March 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more